Company registration number 16008541 (England and Wales)
ALPINE PHARMA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
ALPINE PHARMA LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
ALPINE PHARMA LIMITED
BALANCE SHEET
AS AT 31 OCTOBER 2025
31 October 2025
- 1 -
2025
Notes
£
£
Current assets
Debtors
3
100
Net current assets
100
Capital and reserves
Called up share capital
100

For the financial period ended 31 October 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

T he member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 7 August 2026 and are signed on its behalf by:
Mr J Cattee
Director
Company registration number 16008541 (England and Wales)
ALPINE PHARMA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 OCTOBER 2025
- 2 -
1
Accounting policies
Company information

Alpine Pharma Limited is a private company limited by shares incorporated in England and Wales. The registered office is 11 Manchester Road, Worsley, Manchester, England, M28 3NS.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Profit and loss account

The company has not traded during the period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
Number
Total
0
3
Debtors
2025
Amounts falling due within one year:
£
Other debtors
100
2025-10-31 2024-10-09 false false true 07 August 2026 CCH Software CCH Accounts Production 2026.200 No description of principal activity Mr J Cattee Mr L Goodman Mrs A Bailey 16008541 2024-10-09 2025-10-31 16008541 2025-10-31 16008541 core:WithinOneYear 2025-10-31 16008541 core:ShareCapital 2025-10-31 16008541 bus:Director1 2024-10-09 2025-10-31 16008541 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 16008541 bus:EntityHasNeverTraded 2024-10-09 2025-10-31 16008541 bus:PrivateLimitedCompanyLtd 2024-10-09 2025-10-31 16008541 bus:SmallCompaniesRegimeForAccounts 2024-10-09 2025-10-31 16008541 bus:FRS102 2024-10-09 2025-10-31 16008541 bus:AuditExempt-NoAccountantsReport 2024-10-09 2025-10-31 16008541 bus:Director2 2024-10-09 2025-10-31 16008541 bus:Director3 2024-10-09 2025-10-31 16008541 bus:FullAccounts 2024-10-09 2025-10-31 xbrli:pure xbrli:shares iso4217:GBP